Jan. 11, 2008
Griffith appointed to Andersen-Hebbeln professorship
Thomas Griffith, Ph.D., associate professor of urology in the University of Iowa Roy J. and Lucille A. Carver College of Medicine, has been appointed the Andersen-Hebbeln Associate Professor of Prostate Cancer Research. The five-year appointment was effective Jan. 1.
Griffith is the second UI faculty member to hold the endowed Andersen-Hebbeln Professorship, which was created by gifts to the UI Foundation from the late Wilbur R. Hebbeln and his wife, Elsa (Andersen) Hebbeln, of Waterloo, Iowa. The Hebbelns died in 2001.
Griffith is director of research for the UI Department of Urology and a member of Holden Comprehensive Cancer Center at the UI. He developed a gene therapy approach for prostate cancer and now co-leads a Phase I gene therapy clinical trial to test the dosage at which the therapeutic agent can safely be given to patients. The method is a promising alternative to the current therapy that many prostate cancer patients receive.
"Tom Griffith is an outstanding scientist who is nationally known for his expertise in tumor immunology and is working diligently to translate lab findings directly to the 'bedside'," said Richard Williams, M.D., UI professor and head of urology, who also holds the Rubin H. Flocks Chair. "Tom also motivates and instructs our medical students and residents in basic science research. We appreciate that this appointment will further advance his investigations, scholarship and teaching."
Griffith, who joined the UI in 1999, earned a Bachelor of Science degree in biology from Illinois Wesleyan and a master's degree in biological sciences from Illinois State University. He holds a doctorate in biology and biomedical sciences from Washington University in St. Louis.
The UI acknowledges the UI Foundation as the preferred channel for private contributions that benefit all areas of the university. For more information, visit the UI Foundation's Web site at http://www.uiowafoundation.org.
The Holden Comprehensive Cancer Center is Iowa's only National Cancer Institute (NCI)-designated comprehensive cancer center. NCI-designated comprehensive cancer centers are recognized as the leaders in developing new approaches to cancer prevention and cancer care, conducting leading edge research and educating the public about cancer. Visit the center online at http://www.uihealthcare.com/depts/cancercenter/.
STORY SOURCE: Health Science Relations, University of Iowa, 5137 Westlawn Lawn, Iowa City, IA 52242
MEDIA CONTACT: Becky Soglin, 319-335-6660, email@example.com.